Moreover, lower levels of adiponectin, an anti-inflammatory cytokine inversely associated with NAFLD, insulin-resistance, and impairment in glucose and lipid metabolism [60], have been found in both PNPLA3 GG subjects and obese patients, even without NAFLD [61]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.